Article PDF first page preview

First page of A new bihormonal model for the brain regulation of gonadotropins in teleosts

Background: The brain-pituitary-gonadal tissues play a key role in the neuroendocrine regulation of reproduction in vertebrates. Brain hormones, especially gonadotropin releasing hormone (GnRH) is considered an important stimulant of gonadotropins (luteinizing hormone and follicle stimulating hormone) released from the anterior pituitary. The current concept proposes a single brain hormone (GnRH) stimulating the release of both gonadotropins in fish and mammals. However, two articles published in 2024 propose a dual-hormone concept in the brain regulation of gonadotropins in female medaka and zebrafish. Summary: The emerging concept proposes Gnrh as the Lh releasing hormone (Lh-rh), and a second hormone, cholecystokinin (Cck), as the Fsh releasing hormone (Fsh-rh) in these species. The two studies discussed here found that Cck is a potent Fsh-rh. The line of evidence from the first study to support this notion include abundance of cholecystokinin receptors in the anterior pituitary Fsh-producing gonadotrophs, and severe reproductive defects in female medaka that genetically lacks Cck receptor 2. The second study used zebrafish, and they found hypothalamic expression of cholecystokinin, anterior pituitary abundance of Cck receptors, and an all-male phenotype when Cck receptor 2 was knocked out. In both studies, Cck was found to be a more potent stimulant of intracellular Ca2+, when compared to Gnrh effects. Key Messages: These evidence from two independent studies indicate that Cck is a potent Fsh-rh, and Gnrh is the Lh-rh, and supports a bihormonal model for the regulation of gonadotropin secretion from teleost pituitary. Whether Cck elicits Fsh-rh effects in other fish species remains unknown. In addition, the role of other hormones in the diverse endocrine milieu that regulate reproduction in modulating the phenotype seen in Cck receptor deficient fish also warrants further consideration.

Journal Section:
Review Article
This content is only available via PDF.
S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.